Canada
· Delayed Price · Currency is CAD UnitedHealth Group Statistics
Total Valuation
UnitedHealth Group has a market cap or net worth of CAD 661.51 billion. The enterprise value is 741.32 billion.
| Market Cap | 661.51B |
| Enterprise Value | 741.32B |
Important Dates
The next estimated earnings date is Friday, January 10, 2025.
| Earnings Date | Jan 10, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -1.19% |
| Shares Change (QoQ) | +0.22% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 917.85M |
Valuation Ratios
The trailing PE ratio is 34.20.
| PE Ratio | 34.20 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.16, with an EV/FCF ratio of 41.90.
| EV / Earnings | 38.33 |
| EV / Sales | 1.31 |
| EV / EBITDA | 14.16 |
| EV / EBIT | 16.02 |
| EV / FCF | 41.90 |
Financial Position
The company has a current ratio of 0.91, with a Debt / Equity ratio of 0.75.
| Current Ratio | 0.91 |
| Quick Ratio | 0.83 |
| Debt / Equity | 0.75 |
| Debt / EBITDA | 2.14 |
| Debt / FCF | 5.96 |
| Interest Coverage | 8.63 |
Financial Efficiency
Return on equity (ROE) is 15.25% and return on invested capital (ROIC) is 11.85%.
| Return on Equity (ROE) | 15.25% |
| Return on Assets (ROA) | 6.92% |
| Return on Capital (ROIC) | 11.85% |
| Revenue Per Employee | 1.21M |
| Profits Per Employee | 43,958 |
| Employee Count | 440,000 |
| Asset Turnover | 1.36 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -5.81% in the last 52 weeks. The beta is 0.59, so UnitedHealth Group's price volatility has been lower than the market average.
| Beta (5Y) | 0.59 |
| 52-Week Price Change | -5.81% |
| 50-Day Moving Average | 27.30 |
| 200-Day Moving Average | 25.80 |
| Relative Strength Index (RSI) | 34.54 |
| Average Volume (20 Days) | 50,225 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.81 |
Income Statement
In the last 12 months, UnitedHealth Group had revenue of CAD 532.14 billion and earned 19.34 billion in profits. Earnings per share was 20.78.
| Revenue | 532.14B |
| Gross Profit | 121.71B |
| Operating Income | 43.50B |
| Pretax Income | 27.21B |
| Net Income | 19.34B |
| EBITDA | 47.33B |
| EBIT | 43.50B |
| Earnings Per Share (EPS) | 20.78 |
Balance Sheet
The company has 50.17 billion in cash and 105.39 billion in debt, giving a net cash position of -61.62 billion.
| Cash & Cash Equivalents | 50.17B |
| Total Debt | 105.39B |
| Net Cash | -61.62B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 141.11B |
| Book Value Per Share | 138.37 |
| Working Capital | -12.57B |
Cash Flow
In the last 12 months, operating cash flow was 22.48 billion and capital expenditures -4.79 billion, giving a free cash flow of 17.69 billion.
| Operating Cash Flow | 22.48B |
| Capital Expenditures | -4.79B |
| Free Cash Flow | 17.69B |
| FCF Per Share | n/a |
Margins
Gross margin is 22.87%, with operating and profit margins of 8.18% and 3.63%.
| Gross Margin | 22.87% |
| Operating Margin | 8.18% |
| Pretax Margin | 5.11% |
| Profit Margin | 3.63% |
| EBITDA Margin | 8.89% |
| EBIT Margin | 8.18% |
| FCF Margin | 3.32% |
Dividends & Yields
UnitedHealth Group does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 51.26% |
| Buyback Yield | 1.19% |
| Shareholder Yield | 1.19% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |